Biotech Values

[DewDiligence]

>> It's my understanding from some folks I know in the pharma industry that the FDA is real 'funny' about approving IND's if it's a financially struggling sponsor, this placement addresses that issue, and insures the patients enrolled will start and finish. Nothing is worse than starting a trial and not being able to complete it... <<

You make a compelling argument!